Literature DB >> 18936734

Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit.

M A Trinkaus1, S E Lapinsky, M Crump, A Keating, D E Reece, C Chen, D C Hallett, N Franke, A Winter, J R Mikhael.   

Abstract

Between January 2001 and July 2006, 1013 patients received autologous hematopoietic cell transplants (AHCT) at Canada's largest transplant center. In this retrospective cohort study of AHCT patients admitted to the intensive care unit (ICU), we describe the outcomes following ICU admission and the variables measured in the first 24 h of ICU admission associated with overall ICU mortality. Results indicate a 3.3% ICU admission rate (n=34) with 13 deaths (1% overall mortality rate, 38% in ICU mortality rate). The worst outcome was in AL amyloid patients of whom 28% were admitted to the ICU, with an ICU mortality rate of 55%. The Sequential Organ Failure Assessment (SOFA) score and Acute Physiology and Chronic Health Evaluation (APACHE II) score in the first 24 h were statistically associated with mortality by univariate analysis. Other variables measured at 24 h and associated with ICU mortality included multiorgan failure, mechanical ventilation, inotropic support >4 h and Gram-negative sepsis. Our data indicate that ICU admission in the autotransplant population is rare and that it is influenced by underlying diagnosis, with AL amyloid patients having the highest risk. Our observations may assist clinical decision-making regarding the continuation of intensive care delivered 24 h after ICU admission.

Entities:  

Mesh:

Year:  2008        PMID: 18936734     DOI: 10.1038/bmt.2008.336

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

1.  Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.

Authors:  Ulas D Bayraktar; Elizabeth J Shpall; Ping Liu; Stefan O Ciurea; Gabriela Rondon; Marcos de Lima; Marylou Cardenas-Turanzas; Kristen J Price; Richard E Champlin; Joseph L Nates
Journal:  J Clin Oncol       Date:  2013-10-14       Impact factor: 44.544

Review 2.  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

Authors:  Ulas D Bayraktar; Joseph L Nates
Journal:  World J Clin Oncol       Date:  2016-02-10

3.  Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.

Authors:  Sebastian Mayer; Stephen M Pastores; Elyn Riedel; Molly Maloy; Ann A Jakubowski
Journal:  Leuk Lymphoma       Date:  2016-06-27

4.  Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis.

Authors:  Panagiotis Karagiannis; Lena Sänger; Winfried Alsdorf; Katja Weisel; Walter Fiedler; Stefan Kluge; Dominic Wichmann; Carsten Bokemeyer; Valentin Fuhrmann
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

5.  Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit.

Authors:  Kang An; Ying Wang; Biru Li; Changying Luo; Jianmin Wang; Chengjuan Luo; Jing Chen
Journal:  BMC Pediatr       Date:  2016-08-20       Impact factor: 2.125

6.  Prognostic factors and outcome of adult allogeneic hematopoietic stem cell transplantation patients admitted to intensive care unit during transplant hospitalization.

Authors:  Christian S Michel; Daniel Teschner; Irene Schmidtmann; Matthias Theobald; Beate Hauptrock; Eva M Wagner-Drouet; Markus P Radsak
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.